At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Antithrombotics; Cytoprotectives
- Mechanism of Action Antioxidants; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Shock; Thrombosis